Aerpio Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 12
Employees
  • Stock Symbol
  • ARPO
Stock Symbol
  • Share Price
  • $1.30
  • (As of Wednesday Closing)

Aerpio General Information

Description

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 9987 Carver Road
  • Suite 420
  • Cincinnati, OH 45242
  • United States
+1 (513) 000-0000

Aerpio Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aerpio Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.30 $1.30 $0.42 - $1.90 $54.7M 42.1M 2.11M -$0.09

Aerpio Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 16,296 (17,650) 192 103,704
Revenue 15,000 0 20,157 0
EBITDA (4,207) (24,225) (11,128) (21,244)
Net Income (3,737) (23,271) (10,397) (21,401)
Total Assets 45,716 39,937 64,123 21,028
Total Debt 121 170 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aerpio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aerpio‘s full profile, request access.

Request a free trial

Aerpio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Aerpio‘s full profile, request access.

Request a free trial

Aerpio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular dise
Drug Discovery
Cincinnati, OH
12 As of 2019
00000
000000 - 000 00000

00000000

a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000000
Watertown, MA
00 As of 0000
00000
000000000 00000

00000 00

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
000000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aerpio Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EyePoint Pharmaceuticals Corporation Watertown, MA 00 00000 000000000 00000
00000 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
00000 000000000000 Formerly VC-backed Plano, TX 000 00.000 000000000 00.000
00000 000000000000 Formerly VC-backed San Diego, CA 000 00000 000000 - 000 00000
000000 000000000 Corporation Oxford, United Kingdom 000 00000 000000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Aerpio Executive Team (11)

Name Title Board Seat Contact Info
Joseph Gardner Ph.D Founder, President & Board Member
Kevin Peters Chief Medical Officer, Chief Scientific Officer and Senior Vice President, Research and Development
Sally Graves Controller
Mitchell Brigell Ph.D Vice President of Clinical Development and VP and Director of Clinical Sciences, Ophthalmology
Dhaval Desai Vice President, Medical Affairs
You’re viewing 5 of 11 executive team members. Get the full list »

Aerpio Board Members (19)

Name Representing Role Since
Anupam Dalal MD Kearny Venture Partners Board Member 000 0000
Caley Castelein MD Kearny Venture Partners Board Member 000 0000
Campbell Murray MD Novartis Venture Fund Board Member 000 0000
Chau Khuong Self Board Member 000 0000
Cheryl Cohen Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Aerpio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aerpio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aerpio‘s full profile, request access.

Request a free trial